Paper
Fluorometholone Acetate Ophthalmic Suspension
Published Feb 2, 2020 ·
Definitions
0
Citations
0
Influential Citations
Abstract
An ophthalmic suspension containing the acetate form of fluorometholone, with potential anti-infective and immunosuppressive activities. Upon ocular administration, fluorometholone binds to glucocorticoid receptors in the cytoplasm and forms a receptor-ligand complex, which translocates to the nucleus where it binds to glucocorticoid response elements (GRE) in the promoter region of target genes. This leads to the expression of specific target genes that control inflammation. Specifically, by inducing the expression of lipocortins that inhibit the enzymatic activity of phospholipase A2, the release of arachidonic acid is blocked, which prevents the production of inflammatory mediators, and inflammatory-induced ocular swelling, redness and itching.
Fluorometholone Acetate Ophthalmic Suspension effectively reduces inflammation in the eye by binding to glucocorticoid receptors and inducing specific target genes that control inflammation.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...